ProteoTech, GSK Come Together for Parkinson Drug R&D
Firms aim to bolster ProteoTech’s alpha-synuclein program. GlaxoSmithKline (GSK) has decided to help ProteoTech advance work in its alpha-synuclein therapeutic program. The companies aim to identify small mole…
Read guide →